Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective dysfunction of e-series inflammation resolution in diabetes: the e-series resolution dysfunction index as a novel biomarker in chronic coronary syndrome.

Polish archives of internal medicine·2026
Same author

The RNA helicase DDX53 (CAGE) contributes to RNA metabolism in a human germ cell model.

bioRxiv : the preprint server for biology·2026
Same author

Multi-omic screening identifies RBMXL3 as a primate-specific RNA-binding protein and candidate regulator of RNA metabolism in human spermatogenesis.

Cellular & molecular biology letters·2026
Same author

Mesenchymal Stem Cells From a Klinefelter Syndrome Patient: Functional Characterization and Therapeutic Implications.

Andrology·2026
Same author

Engineered Mesenchymal Stromal Cells in Oncology: Navigating Between Therapeutic Delivery and Tumor Promotion.

Genes·2026
Same author

Impact of sperm fractionation on chromosome positioning, chromatin integrity, DNA methylation, and hydroxymethylation level.

Cellular & molecular biology letters·2025

Related Experiment Video

Updated: Jun 22, 2026

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Cell-based therapy for heart failure: skeletal myoblasts.

Monika Seidel1, Aleksandra Borczyńska, Natalia Rozwadowska

  • 1Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.

Cell Transplantation
|June 9, 2009
PubMed
Summary

Skeletal myoblast transplantation is a feasible therapy for heart failure, but its effectiveness requires further study. Understanding how these cells improve cardiac function is key to advancing this regenerative medicine approach.

More Related Videos

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Related Experiment Videos

Last Updated: Jun 22, 2026

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Cell Biology

Background:

  • Satellite cells in skeletal muscle offer significant regenerative potential, unlike the heart's limited self-renewal capacity.
  • The concept of using skeletal myoblasts to repair heart damage emerged in the mid-1990s, leading to clinical trials.
  • Autologous skeletal myoblast transplantation for heart failure has shown feasibility and relative safety, with arrhythmias as a noted concern.

Purpose of the Study:

  • To evaluate the clinical outcome of skeletal myoblast transplantation for heart failure, clarifying the impact of cell implantation.
  • To investigate the unclear mechanisms by which skeletal myoblasts might improve cardiac function, especially given their lack of electromechanical coupling with host myocardium.
  • To identify key factors for successful myoblast therapy, including delivery, survival, engraftment, differentiation, and integration.

Main Methods:

  • Review of preclinical studies and clinical trials on autologous skeletal myoblast transplantation for heart failure.
  • Analysis of factors influencing the success of myoblast therapy, such as cell delivery, survival, engraftment, differentiation, and integration.
  • Exploration of the mechanisms underlying the therapeutic effects of skeletal myoblasts on cardiac function.

Main Results:

  • Clinical trials indicate that autologous skeletal myoblast transplantation is feasible and relatively safe for treating heart failure.
  • The precise clinical outcomes directly attributable to cell implantation require further elucidation due to concurrent surgical procedures.
  • The mechanism of cardiac function improvement by skeletal myoblasts remains unclear, particularly regarding electromechanical integration.

Conclusions:

  • Further research is essential to clarify the clinical efficacy of skeletal myoblast transplantation and the underlying mechanisms.
  • Understanding the cellular and molecular processes involved is crucial for optimizing myoblast therapy for cardiac repair.
  • Targeting key steps like cell delivery, survival, and integration holds promise for improving therapeutic outcomes in regenerative cardiology.